Safety and Efficacy of Oral LPCN 1021 in Men With Low Testosterone or Hypogonadism

Clinical trial NCT02081300 · COMPLETED

Trial details

NCT number: NCT02081300
Sponsor: Lipocine Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Male Hypogonadism

Start date: 2014-02-01
Primary completion: 2015-05-01
Enrollment: 315

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.